Skip to main content

ZeroStack Corp.

corporate_fare Company Profile

ZeroStack Corp.

ZSTK·NASDAQ·Crypto Assets·CIK 0001790169

ZeroStack Corp. is a decentralized AI treasury and AI-focused asset management company that invests in the future of AI. The company's initial AI-oriented project involves strategic ownership in 0G Tokens. ZeroStack is also a global pharmaceutical distributor through its wholly owned subsidiary, Phatebo GmbH, which has principal operations in Germany. The company was incorporated as Flora Growth Corp. on March 13, 2019, and changed its corporate name to ZeroStack Corp. on January 29, 2026, also changing its Nasdaq ticker from "FLGC" to "ZSTK". In May 2021, the company completed its initial public offering and began trading on the Nasdaq Capital Market. Prior to its IPO, the company engaged in transactions in Colombia, including the acquisition of interests in Flora Growth Corp Colombia S.A.S, Flora Lab S.A.S., Flora Med S.A.S, the Cosechemos Ya S.A.S. cultivation and processing facility, and several brands. Since its IPO, ZeroStack has acquired 100% of the outstanding equity interests in Franchise Global Health Inc. (FGH), which includes Phatebo, and Just Brands LLC and High Roller Private Label LLC, both based in Fort Lauderdale, Florida. Just Brands is a distributor and retailer of cannabidiol derived products through its "JustCBD" brand. On August 4, 2025, the company effected a 1-for-39 share consolidation of its common shares.

ZeroStack Corp. (NASDAQ:ZSTK) is a publicly traded company in the Crypto Assets sector. Wiseek has independently scored 24 items for ZSTK at importance 7 or higher on its 1–10 market-impact scale.

Recent high-impact activity:

  • ZeroStack Announces Transformational Acquisition of Texas Blocker and Major Debt Settlement
  • ZeroStack Earns $2.2M in 0G Token Staking Rewards at 22% APY Since January
  • German Pharma Giant Awards ZeroStack $6.5M Distribution Contract
  • ZeroStack Reports $119.7M Net Loss Driven by $143M Digital Asset Revaluation Loss; CEO Holds 71.65% Stake

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$35.68M
Net Income
-$119.73M
Diluted EPS
-$43.49
Op. Cash Flow
-$8.68M
Free Cash Flow
-$8.8M
Gross Profit
$1.65M
Operating Income
-$154.65M
Cash & Equivalents
$5.6M
Total Debt
$53.49M
Debt / Equity
0.76×
Net Margin
-335.6%
Shares Outstanding
1.05M sh
Source: 10-K · filed 2026-02-27 · accession 0001062993-26-001203
$2.75 -1.79% today
52-week range · as of 2026-11-12 $1.32 – $15.04
Market cap
$61.1M
Volume
91.5K (2.5× avg)
3-mo avg 36.2K
Live data · 2026-11-22 12:55 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed ZSTK - Filings & News (Page 2)

ZSTK
Mar 31, 2026, 5:02 PM EDT
Filing Type: 8-K
Importance Score:
10
Price at Filing: $6.00
Real-time Price: $2.75 info
Change: -$3.25 (-54%) info
Market Cap: $61.097M info
ZSTK
Mar 05, 2026, 8:00 AM EST
Source: TMX Newsfile
Importance Score:
8
Price at Filing: $6.52
Real-time Price: $2.75 info
Change: -$3.77 (-58%) info
Market Cap: $61.097M info
ZSTK
Mar 04, 2026, 9:29 AM EST
Source: TMX Newsfile
Importance Score:
9
Price at Filing: $6.44
Real-time Price: $2.75 info
Change: -$3.69 (-57%) info
Market Cap: $61.097M info
ZSTK
Feb 27, 2026, 4:14 PM EST
Filing Type: 10-K
Importance Score:
9
Price at Filing: $7.94
Real-time Price: $2.75 info
Change: -$5.19 (-65%) info
Market Cap: $61.097M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets